Andrew Reardon - Net Worth and Insider Trading
Andrew Reardon Net Worth
The estimated net worth of Andrew Reardon is at least $1 Million dollars as of 2024-04-28. Andrew Reardon is the See Remarks of Ligand Pharmaceuticals Inc and owns about 16,308 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $1 Million. Details can be seen in Andrew Reardon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew Reardon has not made any transactions after 2023-03-24 and currently still holds the listed stock(s).
Transaction Summary of Andrew Reardon
Andrew Reardon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Reardon owns 1 companies in total, including Ligand Pharmaceuticals Inc (LGND) .
Click here to see the complete history of Andrew Reardon’s form 4 insider trades.
Insider Ownership Summary of Andrew Reardon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2023-08-10 | CHIEF LEGAL OFFICER & |
Andrew Reardon Latest Holdings Summary
Andrew Reardon currently owns a total of 1 stock. Andrew Reardon owns 16,308 shares of Ligand Pharmaceuticals Inc (LGND) as of March 24, 2023, with a value of $1 Million.
Latest Holdings of Andrew Reardon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2023-03-24 | 16,308 | 70.57 | 1,150,856 |
Holding Weightings of Andrew Reardon
Andrew Reardon Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Reardon has made a total of 1 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 300 shares on March 24, 2023, which brought Andrew Reardon around $20,976.
Insider Trading History of Andrew Reardon
- 1
Andrew Reardon Trading Performance
Andrew Reardon Ownership Network
Ownership Network List of Andrew Reardon
Ownership Network Relation of Andrew Reardon
Andrew Reardon Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Andrew Reardon is the CHIEF LEGAL OFFICER & of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include Chief Financial Officer Octavio Espinoza , CEO & President John L Higgins , and EVP and COO Matthew W Foehr .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Andrew Reardon made 1 insider transaction in Ligand Pharmaceuticals Inc (LGND) with a net sale of 300. Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 20,000 shares made by John L Higgins , a net sale of 10,852 shares made by John W Kozarich , and a net sale of 8,301 shares made by Stephen L Sabba .
In summary, during the past 3 months, insiders sold 2,033 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 2,033 shares. During the past 18 months, 41,289 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 37,289 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Andrew Reardon Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Reardon. You might contact Andrew Reardon via mailing address: C/o Ligand Pharmaceuticals Incorporated, 3911 Sorrento Valley Blvd, Suite 110, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
